PL2240570T3 - Sposób wytwarzania cieni bakteryjnych (BG) z zastosowaniem betapropiolaktonu do końcowej inaktywacji bakterii - Google Patents

Sposób wytwarzania cieni bakteryjnych (BG) z zastosowaniem betapropiolaktonu do końcowej inaktywacji bakterii

Info

Publication number
PL2240570T3
PL2240570T3 PL09702047T PL09702047T PL2240570T3 PL 2240570 T3 PL2240570 T3 PL 2240570T3 PL 09702047 T PL09702047 T PL 09702047T PL 09702047 T PL09702047 T PL 09702047T PL 2240570 T3 PL2240570 T3 PL 2240570T3
Authority
PL
Poland
Prior art keywords
betapropiolactone
blp
production process
bacterial ghost
final inactivation
Prior art date
Application number
PL09702047T
Other languages
English (en)
Inventor
Werner Lubitz
Original Assignee
Werner Lubitz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Werner Lubitz filed Critical Werner Lubitz
Publication of PL2240570T3 publication Critical patent/PL2240570T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL09702047T 2008-01-18 2009-01-16 Sposób wytwarzania cieni bakteryjnych (BG) z zastosowaniem betapropiolaktonu do końcowej inaktywacji bakterii PL2240570T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2197708P 2008-01-18 2008-01-18
PCT/EP2009/000272 WO2009090093A1 (en) 2008-01-18 2009-01-16 Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
EP09702047.3A EP2240570B1 (en) 2008-01-18 2009-01-16 Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation

Publications (1)

Publication Number Publication Date
PL2240570T3 true PL2240570T3 (pl) 2014-05-30

Family

ID=40532591

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09702047T PL2240570T3 (pl) 2008-01-18 2009-01-16 Sposób wytwarzania cieni bakteryjnych (BG) z zastosowaniem betapropiolaktonu do końcowej inaktywacji bakterii

Country Status (13)

Country Link
US (1) US7968323B2 (pl)
EP (1) EP2240570B1 (pl)
CN (1) CN102224237B (pl)
AU (1) AU2009204952B2 (pl)
CA (1) CA2710814C (pl)
DK (1) DK2240570T3 (pl)
ES (1) ES2452471T3 (pl)
NZ (1) NZ586669A (pl)
PL (1) PL2240570T3 (pl)
PT (1) PT2240570E (pl)
RU (1) RU2520082C2 (pl)
SI (1) SI2240570T1 (pl)
WO (1) WO2009090093A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101934072B (zh) * 2010-03-24 2012-05-23 天津农学院 一种制备App菌影的方法及App菌影装载巴氏杆菌抗原制备亚单位疫苗的方法
CN101991863B (zh) * 2010-04-28 2012-11-07 中国人民解放军军事医学科学院野战输血研究所 一种双重靶向dna疫苗及其构建方法
PL2591798T3 (pl) * 2011-11-09 2015-04-30 Werner Lubitz Szczepionka do zastosowania w immunoterapii nowotworów
CN103436550B (zh) * 2013-07-26 2015-04-15 黑龙江八一农垦大学 一种菌影载体的构建方法
US9796960B2 (en) * 2014-01-13 2017-10-24 Mingjie Zhang Method for preparing and using cell ghost with active factors as synergist of lymphocyte in vitro culture
WO2015124717A1 (en) * 2014-02-21 2015-08-27 Bird-C Gmbh & Co Kg Fed-batch process for the production of bacterial ghosts
EP3195878A1 (en) 2016-01-22 2017-07-26 Werner Lubitz Bacterial ghosts for the treatment of cancer
KR101825439B1 (ko) 2016-04-15 2018-02-05 배재대학교 산학협력단 염산 처리에 의한 그람양성 박테리아 고스트의 제조 방법
EP3700552A1 (en) 2017-10-25 2020-09-02 Allero Therapeutics BV Treatment of immune diseases by administration of antigen-specific formulations
KR102178334B1 (ko) 2019-01-29 2020-11-12 배재대학교 산학협력단 황산을 이용하는 박테리아 고스트 제조방법, 상기 방법으로 제조된 박테리아 고스트 및 이의 용도
CN110812473A (zh) * 2019-12-10 2020-02-21 广东君睿生物技术研究有限公司 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法
CN110951666A (zh) * 2019-12-27 2020-04-03 江苏农牧科技职业学院 一种双蛋白表达的大肠杆菌菌蜕及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2989435A (en) 1957-01-03 1961-06-20 Philips Corp Method of chemical sterilization of aqueous liquids containing bacteria or spores ofbacteria
DE3715840A1 (de) 1987-05-12 1988-12-01 Boehringer Mannheim Gmbh Fuer ein lytisch wirksames, chimaeres protein kodierende rekombinante dna und ihre verwendung
DE4005874A1 (de) 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
EP0518956A4 (en) 1990-03-07 1993-01-27 Engelhard Corporation Animal feed additive and method for inactivating mycotoxins present in animal feeds
DE69133172T2 (de) 1990-06-07 2003-04-30 Bayer Ag Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
RU2059417C1 (ru) * 1992-10-01 1996-05-10 Данилевич Василий Николаевич Способ стерилизации питательных сред
DE10003241A1 (de) 2000-01-26 2001-08-02 Werner Lubitz Verschließen von Bakterienghosts
EP1404808B1 (en) * 2001-07-11 2010-03-31 Prof. Dr. Lubitz, Werner Nucleic acid free ghost preparations
WO2005001059A2 (en) * 2003-06-23 2005-01-06 Novasterilis Inc. Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
DE10335796A1 (de) 2003-08-05 2005-03-03 Lubitz, Werner, Prof. Dr. Verschliessen von Bakterienghosts durch bioaffine Wechselwirkungen

Also Published As

Publication number Publication date
AU2009204952B2 (en) 2013-02-07
EP2240570B1 (en) 2013-12-11
AU2009204952A1 (en) 2009-07-23
ES2452471T3 (es) 2014-04-01
PT2240570E (pt) 2014-02-17
RU2010134400A (ru) 2012-02-27
WO2009090093A1 (en) 2009-07-23
CN102224237B (zh) 2014-03-12
CN102224237A (zh) 2011-10-19
SI2240570T1 (sl) 2014-04-30
CA2710814C (en) 2014-10-14
US20100092516A1 (en) 2010-04-15
CA2710814A1 (en) 2009-07-23
RU2520082C2 (ru) 2014-06-20
US7968323B2 (en) 2011-06-28
DK2240570T3 (en) 2014-03-10
EP2240570A1 (en) 2010-10-20
NZ586669A (en) 2012-06-29

Similar Documents

Publication Publication Date Title
PT2240570E (pt) Processo de produção de fantasmas bacterianos (bg) utilizando betapropiolactona (blp) para inactivação final
PT2411500T (pt) Processo para a cultura de microrganismo fotossintéticos
HK1150631A1 (en) Microbial alcohol production process
HK1167618A1 (zh) 消毒方法
EP2857199B8 (en) Method for infrared float bar
WO2011090666A9 (en) Methods for treating autism
EP2407457A4 (en) PROCESS FOR THE PREPARATION OF A DIAMIN DERIVATIVE
EP2490530A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2407450A4 (en) METHOD FOR PRODUCING AN OPTICALLY ACTIVE DIAMIDE DERIVATIVE
PL2391391T3 (pl) Sposób sterylizacji
ZA201103570B (en) Microorganism for producing succinic acid
ZA201105741B (en) Methods for isolating bacteria
EP2287300A4 (en) BACTERIA TOXIN VACCINE
EP2399902A4 (en) PROCESS FOR THE PREPARATION OF 2,3-DI-NONLINEARM ALKYL-2-CYANO STARTERIC ACID DIES
EP2405946A4 (en) STERILIZATION PROCESS
EP2383252A4 (en) PROCESS FOR PRODUCING A PRODUCT SUBSTITUTED BY A HYDROXYL GROUP
ZA201202924B (en) Compositions and methods for treating bacterial infections using ceftaroline
EP2390560A4 (en) AIR-PERMEABLE MEMBER AND METHOD FOR ITS PRODUCTION
IL217716A0 (en) Method for producing microbial fermentation product
IL218120A0 (en) Sterilization method
EP2400025A4 (en) PROCESS FOR PRODUCING BACTERIAL FERMENTATION PRODUCT
EP2280698A4 (en) PROCESS FOR INHIBITING BACTERIAL GROWTH
EP2385953A4 (en) METHOD OF REGULATING THE IMMUNE RESPONSE
AU2009905525A0 (en) Process for plant bioactive enrichment
HU0800711D0 (en) Process for extensive growing truffle